Business

'Fall From Grace' — Biotech Crashes 47% To A Record Low - Investor's Business Daily

IB

Published by Investor's Business Daily 3 September 2026 at 17:03

'Fall From Grace' — Biotech Crashes 47% To A Record Low - Investor's Business Daily — Image · Investor's Business Daily

What the report says

The company's experimental Angelman syndrome treatment failed.

Read the full report at Investor's Business Daily →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting